Linezolid for drug-susceptible tuberculosis

Lancet Infect Dis. 2019 Apr;19(4):357. doi: 10.1016/S1473-3099(19)30109-4. Epub 2019 Mar 27.

Authors

Hüseyin Bilgin¹, Elif Tükenmez-Tigen²

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, 34722 Istanbul, Turkey. Electronic address: huseyin.bilgin@marmara.edu.tr.
² Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, 34722 Istanbul, Turkey.

PMID: 30938293
DOI: 10.1016/S1473-3099(19)30109-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Ethambutol
Humans
Linezolid
Prospective Studies
Tuberculosis*
Tuberculosis, Pulmonary*

Substances

Ethambutol
Linezolid